Abstract
Kiwifruits have become one of the most common food sources triggering allergic reactions. In patients suffering from birch pollen related food allergy, reactions result from initial sensitization to the birch (Betula verrucosa) pollen allergen Bet v 1, followed by immunological cross-reactivity to structurally homologous proteins in kiwifruit. Clinical symptoms range from scratching and itching of the oral cavity to more severe immunological reactions such as rhino conjunctivitis. In this work we assigned backbone and side chain 1H, 13C and 15N chemical shifts of the 17 kDa PR-10 allergens Act c 8.0101 and Act d 8.0101 from golden (Actinidia chinesis) and green (Actinidia deliciosa) kiwifruit by solution NMR spectroscopy. The chemical shift data confirm the characteristic Bet v 1 fold for both proteins, consisting of a seven-stranded antiparallel β-sheet interrupted by two short α-helices, along with a long C-terminal α-helix. Our data provide the basis for determining the three-dimensional solution structures of these proteins and characterizing their immunological cross-reactivity on a structural basis.
Keywords: NMR resonance assignment, TALOS + prediction, PR-10 protein, Cross-reactivity, Allergen
Biological context
The most common allergy in Western and Central Europe is pollinosis, elicited by sensitization to birch pollen. About 70–90% of birch pollen allergic patients show IgE serum reactivity against the major birch pollen allergen Bet v 1 (Ipsen and Lowenstein 1983; Moverare 2002). Patients suffering from birch pollinosis frequently experience allergic reactions after consumption of certain fruits and nuts, due to immunological cross-reactivity of Bet v 1 specific antibodies (IgE) to proteins that are present in these food sources. Symptoms typically occur immediately after consumption and are mostly confined to the oral allergy syndrome, which includes itching and scratching of the throat and tongue (Mari et al. 2005). Around 50–60% of all individuals, who are sensitized towards birch pollen, exhibit allergic reactions after consumption of kiwifruit (Geroldinger-Simic, 2011; Le, 2013). Kiwifruit are of high nutritive and health value, with an exceptionally high vitamin C content (Hunter et al. 2011). Kiwifruit allergic patients avoid eating the fruit, thereby abstaining themselves from a valuable food source.
Immunological cross-reactivity to birch pollen is associated with the class 10 pathogenesis related (PR) proteins, Act c 8 and Act d 8, from golden (Actinidia chinensis) and green (Actinidia deliciosa) kiwifruit (Oberhuber, 2008). The expression of these proteins, which are believed to play a major role in plant defense, can be induced by pathogenic or environmental stress. PR-10 proteins consist of about 160 amino acid residues, with a molecular weight of 17–18 kDa. The canonical fold of PR-10 proteins consist of a seven-stranded antiparallel β-sheet (β1–β7), which is interrupted by two short α-helices (α1 and α2) between strands β1 and β2 and covered by a long C-terminal α-helix (Fernandes et al. 2013). Similar to other PR-10 proteins, Act c 8 and Act d 8 are easily degraded by proteolysis and are heat labile (Breiteneder and Mills 2005). In kiwifruit, the allergens Act c 8 and Act d 8 are located in the peripheral pulp. ELISA and immunoblot experiments showed that recombinantly produced Act c 8 and Act d 8 are recognized and bound by IgE in sera of birch pollen allergic patients in vitro, suggesting clinically relevant levels of immunological cross-reactivity with Bet v 1 (Oberhuber et al. 2008).
While the presence of multiple isoforms of Act c 8 and Act d 8, which may possess differential IgE binding potentials, is likely in kiwifruit, only a single isoform of each allergen has been identified so far. Among each other Act d 8.0101 (CAM31909) and Act c 8.0101 (CAM31908.1) share a sequence identity of 70%, while the sequence identity with the birch pollen allergen Bet v 1 is only 53% and 54%, respectively (Gajhede, 1996). The sequence identity of these two kiwi allergens with the most prominent cross-reactive food allergen, Mal d 1 from apple, is 57% and 58% (Ahammer et al. 2017, 2016). A peculiar feature of the two PR-10 allergens from kiwifruit is their unusually high number of cysteine residues.
In this work we present the solution NMR backbone and side-chain assignments of the two recombinantly expressed allergens Act d 8 and Act c 8.
Methods and experiments
Sample preparation
The codon-optimized inserts of Act c 8.0101 (GenBank nucleotide code AM489567.1 and protein code CAM31908.1) and Act d 8.0101 (GenBank nucleotide code AM489568 and protein code CAM31909) were each cloned in the expression vector pET28b (+) using restriction enzymes NcoI and XhoI. Transformation was conducted in the E. coli strain BL21(DE3) Star (Invitrogen). A starter culture (20 mL) of Luria Bertani (LB) medium with 25 µg/mL kanamycin was inoculated with one bacterial colony and incubated for 8 h at 37 °C and 200 rpm. 20 µL of the starter culture were transferred into 100 mL of M9 minimal medium and incubated overnight at 37 °C and 200 rpm. To reach a starting cell density of 0.1 in the final expression culture, the necessary volume of the overnight culture was calculated by Vo/n = (0.1 Vexpression)/A600, o/n. The appropriate volume was centrifuged at 2000g and the pellet was resuspended in 1 L of M9 minimal medium enriched with either 15NH4Cl (1 g/L) or 13C6-d-glucose (3 g/L) and 15NH4Cl (both Cambridge Isotope Laboratories) and supplemented with 25 µg/mL kanamycin. The culture was incubated at 37 °C and 200 rpm until the cell density reached 0.5–0.6 (at 600 nm), at this point, protein expression was induced by addition of isopropyl-β-d-1-thiogalactopyranoside (IPTG, 1 mM) and performed for 3 h at 37 °C. Cells were harvested at 4 °C and 4600g for 40 min, resuspended in a buffer containing 0.5 M urea, 25 mM imidazole and 0.1% Triton X-100 and stored until usage at -80 °C. For lysis, cells were thawed, treated for 40 min on ice with lysozyme (10 µg/mL) and DNAse (1 µg/mL), passed through a French Press and centrifuged at 16,000g and 4 °C for 45 min. The filtered (0.45 µm) lysate was loaded onto an anion exchange column (Resource Q 6 mL, GE Healthcare) and Act d 8.0101 or Act c 8.0101 protein was eluted with a sodium chloride gradient over 30 mL from 0 to 50% in 25 mM TrisHCl buffer (pH 7.5) at a flow rate of 2 mL/min. Fractions containing the desired protein were concentrated to about 1.5 mL by centrifugation (Amicon Ultra 3 kDa MWCO, Merck Millipore) and loaded onto a size exclusion column (HiLoad 16/600 Superdex 75 pg, GE Healtcare) for the final purification step and eluted isocratically at 1 mL/min with a 20 mM sodium phosphate buffer (pH 6.9). Both allergens eluted with a retention time that is in accordance with monomeric PR-10 proteins (Ahammer et al. 2016). SDS-PAGE gel electrophoresis was used to monitor all purification steps. NMR samples were prepared containing 0.5 mM 15N labeled and 15N/13C labeled protein, supplemented with 10% D2O (v/v). No reducing agents were added to NMR samples or during purification.
NMR spectroscopy
All NMR spectra were recorded at 25 °C on 500 MHz Agilent DirectDrive 2 and 700 MHz Bruker Neo Avance spectrometers equipped with room temperature triple-resonance probes. A two-dimensional 1H-15N-HSQC and three-dimensional HNCACB, CBCA(CO)NH, HN(CA)CO and HNCO experiments were used to obtain the backbone resonance assignments. Additionally, a two-dimensional 1H-13C-HSQC and three-dimensional (H)CC(CO)NH-TOCSY, H(CCO)NH-TOCSY, 1H-15N-TOCSY-HSQC, 1H-15N-NOESY-HSQC and 1H-13C-NOESY-HSQC experiments were used for side-chain assignments. Aromatic side-chains of phenylalanines and tyrosines were assigned with aromatic 1H-13C-HSQC experiments. Data was processed with NMRPipe (Delaglio et al. 1995) and the CcpNMR software package was used for resonance assignment (Vranken, 2005).
Assignments and data deposition
We were able to assign the backbone amide resonances of 145 (out of 151) non-proline residues for Act c 8.0101 (Fig. 1a) and 146 (out of 150) non-proline residues for Act d 8.0101 (Fig. 1b). The 1H-15N-HSQC spectra of the two allergens are indicative of well folded proteins in solution (Table 1).
Table 1.
Act c 8.0101 (%) | Act d 8.0101 (%) | |
---|---|---|
C’ | 93.0 | 99.4 |
Cα | 97.5 | 99.4 |
Cβ | 97.3 | 100.0 |
Cγ | 73.0 | 72.5 |
Cδ | 69.5 | 79.1 |
Cε | 72.2 | 87.5 |
HN | 96.7 | 98.0 |
Hα | 92.4 | 94.5 |
Hβ | 94.3 | 95.7 |
Hγ | 78.7 | 81.7 |
Hδ | 72.2 | 90.1 |
Hε | 79.7 | 86.8 |
N | 96.0 | 97.3 |
Nδ | 42.9 | 28.6 |
Nε | 42.9 | 33.3 |
Assignment for backbone amides HN/N corresponds to non-proline residues
The accession numbers at the Biological Magnetic Resonance Data Bank (http://www.bmrb.wisc.edu) are 50811 for Act d 8.0101 and 50812 for Act c 8.0101. We used the TALOS + software (Shen et al. 2009) to predict the secondary structure elements of the two allergens based on their HN, N, C’, Cα and Cβ backbone chemical shifts. Although both allergens only share a sequence identity of 70%, illustrated by the sequence alignment (Fig. 2a), the NMR chemical shifts for both Act c 8 (Fig. 2b) and Act d 8 (Fig. 2c) agree with the canonical PR-10 secondary structure, containing seven β-strands (β1–β7), interrupted by two short α-helices (α1 and α2), and a long α-helix at the C-terminus.
The NMR resonance assignments of Act c 8 and Act d 8 obtained in this work will enable us to analyze structural and dynamic properties of these proteins in a comparative manner, and to investigate their immunological cross-reactivity in detail.
Acknowledgements
Open Access funding was provided by the Austrian Science Fund (FWF). This work was supported by the Austrian Science Fund FWF (P26849) and the Austrian Research Promotion Agency FFG (Project 858017, West-Austrian BioNMR). We thank Dr. Thomas Müller, and Dr. Christina Meisenbichler for mass spectrometry experiments.
Funding
Open access funding provided by University of Innsbruck and Medical University of Innsbruck.
Declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The authors declare that the experiments described in this publication were done in compliance with the ethical standards of the countries in which they were performed.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- Ahammer L, Grutsch S, Kamenik AS, Liedl KR, Tollinger M. Structure of the major apple allergen Mal d 1. J Agric Food Chem. 2017;65:1606–1612. doi: 10.1021/acs.jafc.6b05752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahammer L, Grutsch S, Tollinger M. NMR resonance assignments of the major apple allergen Mal d 1. Biomol NMR Assign. 2016;10:287–290. doi: 10.1007/s12104-016-9685-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Breiteneder H, Mills EN. Molecular properties of food allergens. J Allergy Clin Immunol. 2005;115:14–23. doi: 10.1016/j.jaci.2004.10.022. [DOI] [PubMed] [Google Scholar]
- Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
- Fernandes H, Michalska K, Sikorski M, Jaskolski M. Structural and functional aspects of PR-10 proteins. FEBS J. 2013;280:1169–1199. doi: 10.1111/febs.12114. [DOI] [PubMed] [Google Scholar]
- Gajhede M, et al. X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat Struct Biol. 1996;3:1040–1045. doi: 10.1038/nsb1296-1040. [DOI] [PubMed] [Google Scholar]
- Geroldinger-Simic M, et al. Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies. J Allergy Clin Immunol. 2011;127(616–622):e611. doi: 10.1016/j.jaci.2010.10.027. [DOI] [PubMed] [Google Scholar]
- Hunter DC, Greenwood J, Zhang J, Skinner MA. Antioxidant and 'natural protective' properties of kiwifruit. Curr Top Med Chem. 2011;11:1811–1820. doi: 10.2174/156802611796235134. [DOI] [PubMed] [Google Scholar]
- Ipsen H, Lowenstein H. Isolation and immunochemical characterization of the major allergen of birch pollen (Betula verrucosa) J Allergy Clin Immunol. 1983;72:150–159. doi: 10.1016/0091-6749(83)90523-7. [DOI] [PubMed] [Google Scholar]
- Le TM, et al. Kiwifruit allergy across Europe: clinical manifestation and IgE recognition patterns to kiwifruit allergens. J Allergy Clin Immunol. 2013;131:164–171. doi: 10.1016/j.jaci.2012.09.009. [DOI] [PubMed] [Google Scholar]
- Madeira F, et al. (2019) The EMBL-EBI search and sequence analysis tools APIs in. Nucleic Acids Res. 2019;47:W636–W641. doi: 10.1093/nar/gkz268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mari A, Ballmer-Weber BK, Vieths S. The oral allergy syndrome: improved diagnostic and treatment methods. Curr Opin Allergy Clin Immunol. 2005;5:267–273. doi: 10.1097/01.all.0000168793.27948.b0. [DOI] [PubMed] [Google Scholar]
- Moverare R, et al. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol. 2002;128:325–335. doi: 10.1159/000063855. [DOI] [PubMed] [Google Scholar]
- Oberhuber C, et al. Characterization of Bet v 1-related allergens from kiwifruit relevant for patients with combined kiwifruit and birch pollen allergy. Mol Nutr Food Res. 2008;52(2):S230–240. doi: 10.1002/mnfr.200800146. [DOI] [PubMed] [Google Scholar]
- Shen Y, Delaglio F, Cornilescu G, Bax A. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR. 2009;44:213–223. doi: 10.1007/s10858-009-9333-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vranken WF, et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins. 2005;59:687–696. doi: 10.1002/prot.20449. [DOI] [PubMed] [Google Scholar]